Steven E. Georgeson, M.D. came to Medicor from Temple University Hospital in Philadelphia where he trained in Cardiovascular Disease. Prior to that he completed a fellowship in Clinical Decision Making at Tufts New England Medical Center in Boston and trained in Internal Medicine at Thomas Jefferson University Hospital in Philadelphia. He graduated from New York Medical College in Valhalla, New York with his M.D. degree and from Columbia College in New York with a BA in Computer Science.

Dr. Georgeson has been actively involved in a number of clinical research projects. He is the Principal Investigator in the pivotal Rocket Trial which evaluated a novel blood thinner (Xarelto) as an alternative to Coumadin for patients in Atrial Fibrillation. He has authored several papers which have appeared in peer-reviewed journals, chapters in textbooks and a column in the local newspaper focusing on cardiovascular issues.

In addition to general cardiology, echocardiography and nuclear cardiology, Dr. Georgeson has active interests in adult congenital heart disease and sports cardiology.

Jason O. Hall, M.D., completed his fellowship in interventional cardiology at The Cleveland Clinic, Cleveland, Ohio.

Dr. Hall completed his internal medicine residency and was Chief Resident at UMDNJ-Robert Wood Johnson University Hospital, New Brunswick, NJ after graduating from the University of Delaware and UMDNJ-Rutgers Medical School. He is currently a member of the medical staff at Somerset Medical Center, Robert Wood Johnson University Hospital and Morristown Medical Center.

Under Dr. Hall’s leadership, Medicor Cardiology participates in clinical research studies that help to advance new cardiac care pharmaceuticals. Dr. Hall has co-authored a number of papers related to the treatment of heart disease.

Dr Rachana A. Kulkarni practices noninvasive cardiology and her area of interests are preventive cardiology and heart disease in women. She has dedicated her time and efforts to raising awareness for heart disease in women and has given multiple seminars, both nationally and internationally, to further this cause. She has been recognized by the American Heart Association for her efforts in that field. She currently serves on the executive leadership team of New Jersey’s ‘Go Red For Women’ movement by the American Heart Association.

She has been published extensively and is also a contributing author in cardiology textbooks on heart disease in women. She speaks regularly at seminars to promote healthy lifestyle, to raise awareness of heart disease in the population and and promote leadership in women.

Edward L. Rachofsky, M.D. came to the Somerset medical community in 2009 and joined Medicor Cardiology in 2014. He completed Interventional Cardiology Fellowship and Cardiovascular Diseases Fellowships at New York University Medical Center.

Dr. Rachofsky completed his Internal Medicine Residency at New York Presbyterian Hospital, New York Weill Cornell Campus, where he was Assistant Chief Resident. He holds a M.D. degree and a Ph. D. degree from Mount Sinai School of Medicine and an A.B. degree from Dartmouth College. He is a member of Alpha Omega Alpha medical honor society and was presented with the Mount Sinai School of Medicine Doctoral Dissertation Award. He is a Fellow of the American College of Cardiology.

In his free time, he enjoys travel, skiing, and spending time with his wife and three children.

Dr. Archana M. Patel, MD, FHRS joined Medicor Cardiology in July 2017 following a long tenure at Rutgers-Robert Wood Johnson Medical School, where she was an Assistant Professor of Medicine. Dr. Patel completed her cardiology fellowship at Jersey City Medical Center and her electrophysiology fellowship at Deborah Heart & Lung Center and an additional cardiac electrophysiology/RFA fellowship at Beaumont Hospital in Michigan. She is board certified in clinical cardiac electrophysiology and cardiovascular disease.

Dr. Patel received her undergraduate from Jaihind College and Basantsing Institute of Science, an affiliate of The University of Bombay in India, and her medical school was completed at Topiwala National Medical College and B.Y.L. Nair Hospital in Bombay.

She is a member of the medical staff at Morristown Medical Center, Robert Wood Johnson Barnabas-Somerset and New Brunswick.

Chao-Tarng Cheng, MD, FACC, is the founder of Medicor Cardiology, which he founded in 1977, and he continues to be in active practice. Dr. Cheng completed his Cardiology Fellowship at Case Western Reserve University’s Cleveland Metropolitan General Hospital. He was the Chief Resident at Albert Einstein Medical School’s Lincoln Hospital in Bronx, NY following his first year of residency at Methodist Hospital of Brooklyn and Downstate Medical Center. He graduated from Kaohsiung Medical College in Taiwan.

Dr. Cheng is Board Certified in Internal Medicine and Cardiology. He is a Fellow of the American College of Cardiology and an Assistant Professor at Robert Wood Johnson Medical School in New Brunswick, NJ. Dr. Cheng is a member of the medical staff of Somerset Medical Center and Robert Wood Johnson University Hospital.

Ashok A. Patel, MD, FACC, has been Medicor’s pre-eminent electrophysiologist since joining the practice in 2001. He completed his Fellowship in Clinical Cardiac Electrophysiology at the Lahey Clinic of Tufts University School of Medicine in Burlington, MA following a Cardiology Fellowship at Yale University’s Bridgeport Hospital in Connecticut and Harvard University’s Preventive Cardiology Fellowship at the VA Medical Center in West Roxbury, MA. He is Board Certified in Internal Medicine, Cardiovascular Diseases and Clinical Cardiac Electrophysiology.

Dr. Patel completed his internal medicine residency and was Chief Resident at UMDNJ-Hackensack University Medical Center, Hackensack, NJ after graduating from the B.J. Medical College in Ahmedabad, India. He is currently a member of the medical staff at Somerset Medical Center, Robert Wood Johnson University Hospital and Morristown Medical Center.

At Medicor Cardiology, Dr. Patel directs the Arrythmia Service, which includes the diagnosis of arrhythmias and the surgical insertion of pacemakers and automatic implantable defibrillators (AICD), along with follow-up care.

Daniel T. Fung, MD, FACC joined Medicor Cardiology in the summer of 2018 following his interventional cardiology fellowship at University Hospital of Brooklyn. He received his undergraduate degree from University of Toronto in Ontario where he studied Integrative Biology and Economics and attended medical school at St. George’s University in Grenada.

Dr. Fung is board certified in Internal Medicine, Cardiovascular Disease, and Echocardiography. Dr. Fung specializes in Interventional Cardiology and Vascular Medicine.

Joe K. Ahn, MD, FACC, joined Medicor Cardiology in the summer of 2008 following his internship and residency at Montefiore Medical Center in New York City and his fellowship at North Shore-LIJ Health System in New York. He received his undergraduate degree from Duke University with a double major in Biology and Psychology. It was as a medical student at Sackler School of Medicine/ TAU, where he developed his interest in cardiology.

Dr. Ahn is board certified in Internal Medicine, General Adult Cardiology, Nuclear Cardiology, and Echocardiography. He has a special interest in Trans-Esophageal Echography (TEE).

Dr. Sanjukta S. Sanyal, MD, FACC, FHRS is Board Certified in Cardiology, Internal Medicine and Clinical Cardiac Electrophysiology. She completed her Clinical Cardiac Electrophysiology Fellowship program at Tufts Medical Center and gained expertise in cardiac device management. This expertise includes implantation of pacemakers (including leadless pacemakers), defibrillators and biventricular devices. She is proficient in ablations for cardiac arrhythmias including atrial fibrillation, supraventricular tachycardia and ventricular tachycardia. Dr. Sanyal joined Medicor Cardiology in 2022 as an integral addition to the electrophysiology providers.

Dr. Sanyal’s special interests lie in women’s health issues in cardiovascular disease, arrhythmia and device management, and treatment of atrial fibrillation.